Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
Jihye Park, Jae Hee Cheon
Korean J Intern Med. 2022;37(5):895-905. Published online 2022 Jul 27 DOI: https://doi.org/10.3904/kjim.2022.132
Citations to this article as recorded by 
Polyphenols mitigating inflammatory mechanisms in inflammatory bowel disease (IBD): focus on the NF-ƙB and JAK/STAT pathways
Elysha Nur Ismail, Noraina Zakuan, Zulkefley Othman, Sharmili Vidyadaran, Hussin Mohammad, Reezal Ishak
Inflammopharmacology.2025; 33(2): 759. CrossRef
Anti-Inflammatory Effects of Algae-Derived Biomolecules in Gut Health: A Review
Alessia Brizzi, Rosaria Margherita Rispoli, Giuseppina Autore, Stefania Marzocco
International Journal of Molecular Sciences.2025; 26(3): 885. CrossRef
Hyperbaric Oxygen Therapy in the Treatment of Crohn’s Disease
Jure Krstulović, Goran Augustin, Ivan Romić, Ante Tavra, Franko Batinović, Zrinka Hrgović
Healthcare.2025; 13(2): 128. CrossRef
Zataria multiflora hydroalcoholic extract: A triple-blind randomized controlled trial on immune genes, inflammation, and ulcerative colitis symptoms
Mehrnaz Morvaridi, Naheed Aryaeian, Pezhman Alavinejad, Seyed Saeed Seyedian, Mehri Ghafourian, Nima Bakhtiari, Maryam Seyedtabib
Journal of Ethnopharmacology.2025; 344: 119527. CrossRef
Development of Colon-Targeted Naringin-Loaded Microbeads in Acetic Acid-Induced Colitis Model in Rats for the Management of Inflammatory Bowel Disease
Sonia Chauhan, Ranjit K. Harwansh, Rupa Mazumder
Journal of Pharmaceutical Innovation.2025;[Epub] CrossRef
Traditional herbal pair Portulacae Herba and Granati Pericarpium alleviates DSS-induced colitis in mice through IL-6/STAT3/SOCS3 pathway
Zhe Cheng, Yi Zhou, Xinyu Xiong, Lingli Li, Zekai Chen, Fan Wu, Ruolan Dong, Qiong Liu, Yan Zhao, Shujun Jiang, Qin Yu, Guang Chen
Phytomedicine.2024; 126: 155283. CrossRef
The impact of 5-aminosalicylates on the efficacy of mesenchymal stem cell therapy in a murine model of ulcerative colitis
Huanhuan Chen, Huimin Wang, XiaoJing Xu, Ya'nan Hu, Jing Su, Dongdong Li, Zimu Li, Shixiang Feng, Jinming Liu, Huanxiang Zhang, Xiaoyan Wang
International Immunopharmacology.2024; 134: 112255. CrossRef
The Impact of Microbiome Interventions on the Progression and Severity of Inflammatory Bowel Disease: A Systematic Review
Malik Kasapoglu, Rajesh Yadavalli, Sarosh Nawaz, Abdulaziz Althwanay, Esraa M AlEdani, Harleen Kaur, Samia Butt
Cureus.2024;[Epub] CrossRef
Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers?
Alberto Repici, Ahmed Hasan, Anna Paola Capra, Sarah Adriana Scuderi, Irene Paterniti, Michela Campolo, Alessio Ardizzone, Emanuela Esposito
Marine Drugs.2024; 22(8): 336. CrossRef
Aloe-emodin alleviates inflammatory bowel disease in mice by modulating intestinal microbiome homeostasis via the IL-4/IL-13 axis
Dong Yang, Tingrui Ge, Jingyi Zhou, Huazhuan Li, Yonggang Zhang
Heliyon.2024; 10(15): e34932. CrossRef
Inflammatory bowel disease is associated with greater odds of complications following posterior lumbar fusion and further amplified for patients exposed to monoclonal antibody biologics
Anthony E. Seddio, Beatrice M. Katsnelson, Julian Smith-Voudouris, Michael J. Gouzoulis, Wesley Day, Sahir S. Jabbouri, Rajiv S. Vasudevan, Daniel R. Rubio, Jonathan N. Grauer
North American Spine Society Journal (NASSJ).2024; 20: 100574. CrossRef
Natural products targeting Nrf2/ARE signaling pathway in the treatment of inflammatory bowel disease
Botong Li, Yixuan Wang, Xiaolin Jiang, Hongwei Du, Yan Shi, Minghui Xiu, Yongqi Liu, Jianzheng He
Biomedicine & Pharmacotherapy.2023; 164: 114950. CrossRef
Mesalazine-induced esophageal ulcers. a rare adverse effect
Raúl José Díaz Molina, Carlos Comesaña Castellar, Marcelo García Hernández, Carmen Garrido Durán, Marco Antonio Martínez Ortega, Daniel Ginard Vicens
Revista Española de Enfermedades Digestivas.2023;[Epub] CrossRef
Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches
Catherine O’Reilly, Susan Mills, Mary C. Rea, Aonghus Lavelle, Subrata Ghosh, Colin Hill, R. Paul Ross
Microbiome Research Reports.2023;[Epub] CrossRef
Microbial Modulation in Inflammatory Bowel Diseases
Jongwook Yu, Jae Hee Cheon
Immune Network.2022;[Epub] CrossRef